When scans and blood tests disagree, AI could help oncologists decide what to do next
A new narrative review proposes a five-dimensional taxonomy for disagreements between imaging and circulating tumor DNA testing and frames multimodal ...
A new narrative review proposes a five-dimensional taxonomy for disagreements between imaging and circulating tumor DNA testing and frames multimodal ...
A urine-based DNA methylation marker, TAGMe, was associated with poorer outcomes in urothelial carcinoma and improved preoperative risk prediction in ...
A new review maps four molecular routes by which CRISPR systems can detect cancer-linked DNA methylation in cell-free DNA, and ...
A comprehensive review maps why liquid biopsy tests for early cancer detection struggle to translate from promising studies into approved ...
A gold nanoparticle-decorated MBene thin-film transistor array detected salivary microRNA-27a down to 3.2 femtomolar and distinguished a small preliminary cohort ...
A case report in Oncotarget describes how an international molecular tumor board weighed treatment options for a 52-year-old woman with ...
A nearly 1,800-patient international observational study found that the investigational PANXEON blood test detected 87% of stage 1 and 2 ...
A prospective observational study linked circulating tumor DNA fraction and copy-number burden with progression and survival in 78 patients receiving ...
The 35,878-person PATHFINDER 2 trial found 6.5-fold more cancers when Galleri was added to routine screening, but it did not ...
A prospective study found that a multicancer blood test detected signals across 17 cancer types with 99.64% specificity, but randomized ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine